Opendata, web and dolomites

ChondroCONNECT SIGNED

Development of a connexon-proteoliposome delivery system to ameliorate inflammatory and mechanical stress responses in the regeneration of osteoarthritic cartilage

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ChondroCONNECT project word cloud

Explore the words cloud of the ChondroCONNECT project. It provides you a very rough idea of what is the project "ChondroCONNECT" about.

incorporate    cartilage    independence    rna    connexin    untargeted    repair    limiting    therapy    upregulated    protein    proteoliposomes    expression    junction    interfering    chondrocytes    abundant    vitro    pl    culture    bypasses    refine    skills    clear    regenerate    exceptional    oa    strategies    questions    therapeutic    mechanistic    metabolomics    rcsi    si    encapsulate    molecules    environment    mechanism    efficacy    responsive    perform    training    osteoarthritis    linked    scaffold    phenotypes    cx    small    royal    cues    platform    cells    metabolite    stimuli    shifts    ireland    senescence    endosome    surgeons    chondrocyte    regulation    shown    metabolic    cx43    screens    degenerative    collagen    healthy    supplementing    gap    complementary    bioactive    gene    signalling    scaffolds    fellowship    roles    me    sirna    connexons    cell    restore    pls    mechanical    hyaluronic    metabolism    knockdown    escape    situ    inflammation    prof    regenerative    containing    expedite    acid    college    proinflammatory    disease    brien    promise    medicine    engineered   

Project "ChondroCONNECT" data sheet

The following table provides information about the project.

Coordinator
ROYAL COLLEGE OF SURGEONS IN IRELAND 

Organization address
address: Saint Stephen's Green 123
city: DUBLIN
postcode: 2
website: www.rcsi.ie

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Total cost 196˙590 €
 EC max contribution 196˙590 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2019
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2020
 Duration (year-month-day) from 2020-07-01   to  2022-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ROYAL COLLEGE OF SURGEONS IN IRELAND IE (DUBLIN) coordinator 196˙590.00

Map

 Project objective

Regenerative medicine strategies using engineered scaffolds have shown promise to regenerate cartilage in degenerative conditions (e.g. osteoarthritis, OA). However, it is clear further cues are required to control repair in situ. Small interfering (si)RNA can control protein expression but current cell delivery methods require endosome escape, limiting efficacy. Cell delivery of small molecules through connexons (Cx) bypasses the endosome and can be achieved by gap junction formation between cells and engineered Cx-containing proteoliposomes (Cx-PL). The most abundant connexin (Cx43) in cartilage cells (chondrocytes) is also a promising OA therapeutic target. It is highly upregulated in OA and is linked to inflammation, senescence, metabolic shifts and gene regulation. However, many questions remain on its mechanistic role in the disease. This project focuses on Cx43 as a therapeutic target and a delivery mechanism and aims to i) Investigate Cx43 roles in response to OA-associated proinflammatory and mechanical stimuli ii) Develop a Cx-PL delivery platform to knockdown Cx43 and restore healthy metabolism in OA. To study this I will assess chondrocyte responses to proinflammatory and mechanical signalling while controlling Cx43 expression and activity in culture. Using untargeted metabolomics, I will identify key responsive metabolic pathways and perform in vitro screens of the effects of supplementing these to promote healthy phenotypes. Finally, I will encapsulate Cx43-siRNA and a selected bioactive metabolite in Cx43-PLs, incorporate these into a collagen I-hyaluronic acid scaffold and test this delivery platform in vitro. This fellowship conducted with Prof. O’Brien at the Royal College of Surgeons in Ireland will enable me to build on my existing skills in two emerging fields- siRNA therapy and PL-delivery, while the exceptional training environment at RCSI will allow me to refine complementary skills that will expedite my research independence.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CHONDROCONNECT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CHONDROCONNECT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

ProTeCT (2019)

Proteasome as a target to combat trichomoniasis

Read More  

PROTEAN (2019)

Prospective Environmental Assessment of Urban Agriculture Emerging-Systems

Read More  

ASIQS (2019)

Antiferromagnetic spintronics investigated by quantum sensing techniques

Read More